SCHEMBL17215907

SCHEMBL17215907

Cc1ccccc1CON=[C]c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
KDM4E B2RXH2 3/20 0.38
LMNA P02545 2/20 0.38
ALOX5 P09917 2/20 0.37
ALOX5AP P20292 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MAOB P27338 1/20 0.36
SLC6A4 P31645 2/20 0.34
MAPT P10636 2/20 0.34
HTR2A P28223 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
METAP2 P50579 1/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17215906 1.00 TP53 (0.38) TP53PPARGPPARAKDM4ELMNA
SCHEMBL17218492 0.88 MAOB (0.38) KDM4ENPC1RAB9AMAOBMAPT
SCHEMBL17218495 0.88 MAOB (0.38) KDM4ENPC1RAB9AMAOBMAPT
SCHEMBL17217447 0.87 MAOB (0.40) KDM4EMAOBALDH1A1HPGDKMT2A
SCHEMBL17217446 0.87 MAOB (0.40) KDM4EMAOBALDH1A1HPGDKMT2A
SCHEMBL17218399 0.85 MAOB (0.42) TP53KDM4ENPC1RAB9AMAOB
SCHEMBL17216631 0.85 MAOB (0.36) KDM4ENPC1RAB9AMAOBALDH1A1
SCHEMBL17216596 0.85 NPC1 (0.40) KDM4ELMNANPC1RAB9AMAOB
SCHEMBL17216629 0.85 MAOB (0.36) KDM4ENPC1RAB9AMAOBALDH1A1
SCHEMBL17217441 0.85 MAOB (0.36) TP53KDM4ENPC1RAB9AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2940012-B1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL CO (JP) 2019-01-30 EP disclosed
US-9560850-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-07 US disclosed
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 US disclosed
EP-2940012-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF Sumitomo Chemical Company Limited (JP) 2015-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF RTN3, CYP51A1, TCOF1 TP53 4563/4885PPARG 3030/4885PPARA 2794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.